Diarrhea is a medical condition characterized by the passage of loose or liquid stools with increased frequency, typically more than three times a day, and sometimes in larger volumes than usual. Diarrhea can be caused by poor nutrition, bacterial, viral, or parasitic infections, gastrointestinal inflammation, non-gastroenterological diseases, use of various medications, or psychological stress.
Pathophysiologically, diarrhea results from one or more of the following mechanisms: impaired absorption of water and electrolytes in the intestine, increased secretion of fluids into the intestinal lumen, accelerated intestinal motility, or damage to the intestinal mucosa.
Clinically, diarrhea is classified by duration:
Diarrhea may be accompanied by additional symptoms such as abdominal pain, bloating and gas, fever, blood or mucus in the stool, unexplained weight loss, and signs of dehydration. The clinical significance and the need for medical investigation depend on the duration of the symptom, its severity, the patient's age, and the presence of warning signs.
Irritable Bowel Syndrome (IBS) is a functional disorder of the digestive system rather than a structural organic disease. This means that imaging, endoscopy, or laboratory tests typically do not reveal a clear pathological finding, despite the presence of significant symptoms.
Patients with IBS may report a wide range of symptoms, including recurrent abdominal pain, bloating, excessive gas, diarrhea, constipation, or a combination of both, and sometimes nausea and persistent abdominal discomfort. Symptoms tend to vary in intensity and character over time and are often exacerbated after eating.
Pathophysiologically, the syndrome is linked to a disturbance in the brain-gut axis, visceral hypersensitivity, changes in intestinal motility, and sometimes alterations in the gut microbiota. In many cases, psychological factors such as stress, pressure, and anxiety have a significant impact and can trigger or worsen symptoms.
Diagnosis is based on clinical criteria after ruling out other organic diseases, especially in the absence of "red flag" warning signs such as gastrointestinal bleeding, unexplained weight loss, or anemia. Treatment includes pharmacological, dietary, and sometimes psychological interventions.
Previously known in Hebrew as "Machalat HaKereset", it is characterized by sensitivity to gluten, the protein found in grains. It can be diagnosed at any age.
Symptoms may include abdominal pain, diarrhea, iron deficiency anemia, early calcium loss, and more. Diagnosis is established by combining a blood test (serology) and a duodenal biopsy taken during a gastroscopy.
Ulcerative Colitis is a chronic inflammatory disease that belongs to the group of inflammatory bowel diseases (IBD), which is characterized by persistent inflammation of the mucosal lining of the colon only. The inflammation always involves the rectum and may spread continuously along the entire length of the colon, and in rare cases also to the terminal portion of the small intestine.
The disease causes the formation of ulcers and sores in the inner wall of the colon, and depending on the extent of inflammation, the severity of symptoms varies: abdominal pain, frequent diarrhea (sometimes with blood or pus), urgency of bowel movements, weight loss, fatigue, fever, and in some cases impaired growth in children.
The disease is characterized by periods of flare-ups and remission, and can manifest at any age but is most common between ages 15-30. The exact cause is unknown, but the hypotheses suggest a combination of genetic, environmental, and an excessive immune response against beneficial gut bacteria or foreign pathogens, leading to an uncontrolled inflammatory reaction. Ulcerative Colitis requires ongoing medication and usually also gastroenterological follow-up.
The medications are intended to suppress the inflammation and to regulate immune system activity. In severe cases and in the event of complications, surgery for partial or total removal of the colon may be required. There are currently about 21,000 people with Ulcerative Colitis in Israel, and in recent years the incidence has increased in Western countries.
Diagnostic tests include, among others, colonoscopy and blood tests, as well as a new video capsule test that enables full and non-invasive scanning of the colon to evaluate inflammation and monitor the disease.